<DOC>
	<DOCNO>NCT01606800</DOCNO>
	<brief_summary>The purpose study assess efficacy short course therapy ( 24 week ) versus standard 48 week treatment previously untreated adult participant chronic hepatitis C ( CHC ) genotype 4 infection achieve rapid virologic response ( RVR ) , define HCV ribonucleic acid ( RNA ) negativity 4 week treatment .</brief_summary>
	<brief_title>Efficacy Safety Short Course Therapy With Peginterferon Alpha-2b ( PEG-IFN Alfa-2b ) Ribavirin ( RBV ) Chronic Hepatitis C ( Genotype 4 ) Participants Achieving Rapid Virological Response Week 4 Treatment ( MK-8908B-059 )</brief_title>
	<detailed_description>Participants achieve RVR 4 week PEG-INF alfa-2b plus RBV treatment randomize receive either 20 44 week continue therapy , total 24 48 week total PEG-INF plus RBV therapy .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Participant ≥40 kg ≤120 kg weight Participant participant 's partner ( ) must agree use acceptable method contraception least 2 week prior Day 1 continue least 6 month last dose study medication , longer dictate local regulation . Previously document CHC genotype 4 infection Liver biopsy fibrotest fibroscan histology consistent CHC etiology hepatic fibrosis score ( F0 , F1 , F2 , F3 ) . Coinfected human immunodeficiency virus ( HIV ) hepatitis B virus Treatment hepatitis C investigational medication Treatment investigational drug within 30 day screen visit Evidence decompensated liver disease include , limited , history presence clinical ascites , bleed varix , hepatic encephalopathy Autoimmune hepatitis history autoimmune disease Hepatic fibrosis score F4 Severe preexist cardiac disease , include unstable uncontrolled cardiac disease previous six month Autoimmune hepatitis history autoimmune disease Thyroid disease uncontrolled conventional treatment Epilepsy and/or compromise central nervous system ( CNS ) function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>